Does a Series C insurtech company need a fractional CRO in 2027?

Direct Answer

A Series C insurtech in 2027 faces a specific set of revenue challenges: long enterprise sales cycles to carriers and MGAs, compliance-heavy procurement, and the need to build a sales operations function that can handle multiple distribution channels. A fractional CRO can address these without the full-time executive compensation package (which for a Series C insurtech can run $350,000–$500,000 total cash plus significant equity). The honest trade-off is that a fractional CRO cannot be on-site every day or attend every board meeting, but they bring pattern recognition from having built revenue engines at other insurtechs and B2B SaaS companies. If your current revenue leader is strong on execution but weak on strategy, or if you lack a repeatable sales process, a fractional CRO is a practical bridge.

The real revenue challenges at Series C insurtech

By Series C, your insurtech has likely raised $30–$60 million and is under pressure to show a path to $10–$20 million in ARR with predictable growth. The problem is that insurtech revenue models are rarely simple. You may sell to carriers (enterprise), to brokers (mid-market), or directly to consumers (B2C). Each channel requires a different sales motion, different contract terms, and different compliance approvals. A full-time CRO who has only worked in standard B2B SaaS may struggle with the regulatory and underwriting complexity. A fractional CRO who has done this before—perhaps at a prior insurtech or at a company selling into regulated industries—brings that pattern recognition without the long-term commitment.

The honest reality is that many Series C insurtechs are not ready for a full-time CRO. They may have a VP of Sales who is good at closing but not at building process, or a CEO who is still the de facto CRO. In those cases, a fractional CRO can act as a strategic advisor and execution coach while the company grows into the need for a full-time executive. The fractional CRO can also help you avoid the common mistake of hiring a "rockstar" CRO who looks good on paper but cannot navigate the specific insurtech ecosystem.

What a fractional CRO actually does for an insurtech

A fractional CRO at a Series C insurtech typically focuses on four areas:

1. Sales process design – Defining a repeatable sales methodology that works for both carrier and broker channels. This includes creating a qualification framework, deal stages, and a CRM structure in Salesforce or HubSpot.
2. Team coaching and hiring – Working with your existing sales team to improve close rates, and helping you hire the right VP of Sales or Director of Channel Partnerships. The fractional CRO does not replace your team; they make them better.
3. Deal strategy and execution – Jumping into your largest carrier or broker deals to help negotiate terms, navigate compliance, and close. This is especially valuable if your CEO is stretched thin.
4. Revenue operations – Setting up the reporting, forecasting, and pipeline reviews that give you visibility into your business. Many insurtechs at Series C still run revenue on spreadsheets; a fractional CRO can fix that.

The fractional CRO is not a permanent fix. They are a temporary force multiplier who should leave behind a documented playbook, a trained team, and a clear hiring plan for a full-time CRO or VP of Sales.

When you should NOT hire a fractional CRO

There are honest situations where a fractional CRO is the wrong choice. If your insurtech already has a strong VP of Sales who owns process, a data-driven revenue operations team, and a repeatable sales motion that is scaling well, then a fractional CRO may add overhead without much value. Similarly, if your board expects a full-time CRO in the seat for every board meeting and weekly strategy sessions, a fractional arrangement may feel insufficient.

Another warning sign: if your company culture requires the revenue leader to be in the office five days a week, or if your sales team is large (say, 20+ reps) and needs constant hands-on management, a fractional CRO may not be able to give the attention required. In those cases, hire a full-time CRO and use a fractional executive as a temporary interim while you search.

How to find the right fractional CRO for your insurtech

Not all fractional CROs are created equal. For an insurtech, you need someone who has sold into regulated industries—preferably insurance, fintech, or healthcare. They should understand the difference between selling to a carrier (where the buyer is a VP of Underwriting or Chief Actuary) versus selling to a broker (where the buyer is a Principal or Agency Owner). They should also be comfortable with the compliance and legal hurdles that come with insurance data and contracts.

When interviewing, ask for specific examples of how they built a sales process at a company with multiple distribution channels. Ask how they handled a deal that stalled in underwriting review. Ask what CRM and revenue intelligence tools they have used (Salesforce, HubSpot, Gong, Clari, Outreach, Salesloft). Do not hire a fractional CRO who cannot name the tools and processes they have built.

The cost breakdown honestly

Fractional CRO pricing for a Series C insurtech in 2027 is not a single number. It depends on:

• Scope – Are you asking for 10 days a month or 20? More days means higher cost.
• Equity – Some fractional CROs will accept a lower cash rate in exchange for equity (typically 0.5%–2% of the company). This is common in earlier-stage insurtechs but less so at Series C.
• Travel – If the fractional CRO needs to be on-site at your office or at carrier meetings, travel costs add $2,000–$5,000 per month.
• Complexity – If your insurtech sells into multiple channels (carriers, brokers, direct) with long sales cycles, the fractional CRO will charge more because the work is harder.

A realistic range: $15,000–$35,000 per month for 10–20 days of engagement. Some fractional CROs charge a flat monthly retainer; others charge a day rate of $1,500–$3,000. At the high end, you are paying for a CRO who has deep insurtech networks and can open doors at major carriers.

FAQ

Is a fractional CRO only for early-stage startups? No. Series C insurtechs often benefit most because they have enough revenue to need a strategic leader but not enough complexity to justify a full-time CRO. Fractional CROs are common at Series B through Series D.

Will a fractional CRO attend board meetings? Usually yes, but only for the board meetings that cover revenue and go-to-market topics. They will not attend every board meeting unless you specifically contract for that.

How do I measure the success of a fractional CRO? Set clear KPIs at the start: pipeline coverage ratio, sales cycle length, win rate, and team ramp time. The fractional CRO should also leave behind a documented sales playbook and a trained team.

Can a fractional CRO help with fundraising? Yes. A fractional CRO can build the revenue model and forecast that investors want to see. They can also join investor calls to answer questions about go-to-market strategy.

What if I already have a VP of Sales? A fractional CRO can coach your VP of Sales and help them level up. This is a common arrangement where the VP of Sales is strong on execution but needs strategic guidance.

Do fractional CROs work remote or on-site? Most work hybrid. They will come on-site for key meetings, deal reviews, and quarterly planning, but the day-to-day work is remote. This is standard for insurtechs outside major hubs.

Sources

• Pavilion – Fractional executive community
• RevOps Co-op – Revenue operations resources
• Harvard Business Review – On fractional executives
• First Round Review – Sales leadership advice
• SaaStr – Go-to-market insights
• LinkedIn – Fractional CRO groups and discussions

People also search for: fractional cro · hire a fractional cro · fractional cro near me · fractional cro cost